Moreover, expression of a number genes—potential therapeutic targets in liver diseases—including EGFR, GLUD1, GNL3, and RGS5, has been shown to be modified by dietary fats and should be further investigated in this regard. This evidence concerns the gene GNL3 and liver disorder.